[Three Cases of Moyamoya Disease with a History of Kawasaki Disease]
Related Experiment Video
Updated: Mar 30, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Toshinari Kawasaki1, Yoshiki Arakawa, Toshiya Sugino
1Department of Neurosurgery, Kyoto University School of Medicine.
Insights
This study highlights three cases of moyamoya disease in patients with a history of Kawasaki disease, emphasizing the potential link and the need for vigilance in monitoring neurological symptoms. Early detection and intervention are crucial for managing this rare cerebrovascular condition.
Area of Science:
- Neurology
- Pediatrics
- Vascular Surgery
Background:
- Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by stenosis or occlusion of the terminal internal carotid arteries (ICAs) and the development of collateral vessels.
- Kawasaki disease is an acute febrile illness that can affect blood vessels, including coronary arteries, but its association with moyamoya disease is less commonly reported.
Observation:
- Three pediatric and adult cases are presented, all with a documented history of Kawasaki disease treated with immunoglobulin or aspirin.
- Patients presented with varying neurological symptoms, including headache, lisping, and epilepsy, alongside diagnosed moyamoya disease.
- Diagnostic imaging revealed stenotic lesions in the ICAs, with some cases showing progression of stenosis and cerebral blood flow impairment over time.
Findings:
- The cases suggest a potential association between Kawasaki disease and the development of moyamoya disease, particularly in individuals with a history of this childhood illness.
- Despite initial mild or absent ischemic lesions on MRI, angiography confirmed significant ICA stenosis in all reported cases.
- Surgical interventions, including encephaloduroarteriosynangiosis and bilateral direct bypass, were performed in response to worsening symptoms and progressing disease.
Implications:
- This report underscores the importance of considering moyamoya disease in patients with a history of Kawasaki disease, especially those presenting with neurological deficits.
- Further research is warranted to elucidate the underlying mechanisms connecting Kawasaki disease and moyamoya disease.
- Enhanced surveillance and timely neurovascular assessment may be beneficial for individuals with a history of Kawasaki disease to detect and manage moyamoya disease effectively.
Abstract:
Here, we report three cases of moyamoya disease with a history of Kawasaki disease. A 33-year-old man was found to have stenotic lesions of the internal carotid arteries(ICAs)on both sides at a nearby hospital where he visited complaining of headache and lisping. He had received immunoglobulin therapy for Kawasaki disease at the ages of 1, 2, and 6 years. MRI showed only a chronic ischemic lesion in the white matter. Angiography showed occlusion at the terminal portion of the ICAs on both sides. He was diagnosed with moyamoya disease, but as he had no symptoms and preserved cerebral blood flow (CBF), he was kept under observation. An 8-year-old boy was diagnosed with moyamoya disease and underwent right encephaloduroarteriosynangiosis at a nearby hospital. He had received immunoglobulin therapy for Kawasaki disease at the age of 1 year. His ischemic symptoms worsened. Although MRI detected no apparent ischemic lesion, angiography revealed severe stenosis at the terminal portions of the ICAs on both sides, and 123I-IMP SPECT showed CBF impairment. Bilateral direct bypass was performed. His father was subsequently also diagnosed with moyamoya disease. A 4-year-old girl with epilepsy was diagnosed with moyamoya disease at a nearby hospital. She had been treated with aspirin for Kawasaki disease at the age of 1 year. MRI detected no remarkable ischemic lesions, but angiography revealed mild stenosis at the terminal portions of the ICAs on both sides. Five months later, her ischemic symptoms were worsening with progressing stenotic lesions, and she underwent bilateral direct bypass.
More Related Videos
06:54A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
08:56Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Related Concept Videos
Mitral Stenosis I: Introduction
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Mitral Stenosis II: Clinical features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis III: Medical Management